Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Psychopharmacotherapy compliance in catatonic and paranoid type of schizophrenia (CROSBI ID 584425)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Mimica, Ninoslav ; Folnegović-Šmalc, Vera ; Mimica, Nevenka ; Uzun, Suzana ; Kozumplik, Oliver ; Vilibić, Maja Psychopharmacotherapy compliance in catatonic and paranoid type of schizophrenia // Schizophrenia research / Crow, Timothy J. ; Hirsch, Steven R. (ur.). 2004. str. 194-195

Podaci o odgovornosti

Mimica, Ninoslav ; Folnegović-Šmalc, Vera ; Mimica, Nevenka ; Uzun, Suzana ; Kozumplik, Oliver ; Vilibić, Maja

engleski

Psychopharmacotherapy compliance in catatonic and paranoid type of schizophrenia

Objective: The aim of this study was to compare psychopharmacotherapy compliance in catatonic with paranoid schizophrenia. Methods: From a base population of 10569 schizophrenic patients recorded in the Croatian Psychotics Case Register (CPRC), a representative sample of 402 patients (207 males and 195 females) was formed for further long-term field- clinical- epidemiological follow-up. In this sample there were 59 (14.7%) patients, who were diagnosed at least once in their life as catatonic schizophrenia (ICD and DSM). Every catatonic patient was matched to one with paranoid schizophrenia from the sample, according to residential area, sex and age. The patients were followed up for more than 25 years. The compliance status was assessed in the beginning of the illness and approximately 20 years later. Results: Age, sex and employment status were not found to be significantly associated with psychopharmacotherapy compliance. Good compliance was recorded more often in patients with catatonic schizophrenia (72.9% ; 59.3%) than in group of patients with paranoid schizophrenia (64.4% ; 54.2%). In both groups there was a significant drop of psychopharmacotherapy compliance between two observed intervals. Conclusion: During 20-year follow-up of catatonic and paranoid schizophrenic patients no significant difference in psychopharmacotherapy compliance was found. Variety of different methods (psychosocial interventions, education about illness for patients and relatives, anti stigma program, simple drug regiment etc.) should be applied to improve psychopharmacotherapy compliance in patients with schizophrenia. References: Mimica, N., Folnegović-Šmalc, V., Folnegović, Z., 2001. Catatonic schizophrenia in Croatia, European Archives of Psychiatry and Clinical Neuroscience 251 (Suppl 1), I/17-I/20. Mimica, N., Folnegović-Šmalc, V., Folnegović, Z., Makarić, G., 1998. Comparative study of patients with catatonic type of schizophrenia and other schizophrenics in a representative sample of Croatia. Psychiatria Danubina 10 (2), 160-163. Buchanan A., 1996. Compliance with treatment in schizophrenia. Psychology Press, Hove, UK.

Psychopharmacotherapy ; Compliance ; Catatonic schizophrenia ; Paranoid schizophrenia

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

194-195.

2004.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Schizophrenia research

Crow, Timothy J. ; Hirsch, Steven R.

Amsterdam: Elsevier

0920-9964

Podaci o skupu

XIIth Biennial Winter Workshop on Schizophrenia

poster

07.02.2004-13.02.2004

Davos, Švicarska

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost